DraftKings To Rally Over 38%? Here Are 10 Other Analyst Forecasts For Tuesday
Portfolio Pulse from Lisa Levin
Several companies have had their price targets adjusted by analysts. Piper Sandler raised the price target for Chegg, Inc. (CHGG) from $11 to $13, while Atlantic Equities cut Biogen Inc.'s (BIIB) price target from $282 to $275. Goldman Sachs boosted the price target for Paymentus Holdings, Inc. (PAY) from $9 to $12, and JP Morgan increased the price target for Sovos Brands, Inc. (SOVO) from $21 to $23. Other companies with adjusted price targets include Genius Sports Limited (GENI), Enanta Pharmaceuticals, Inc. (ENTA), Axsome Therapeutics, Inc. (AXSM), Datadog, Inc. (DDOG), DraftKings Inc. (DKNG), Coinbase Global, Inc. (COIN), and Five9, Inc. (FIVN).
August 08, 2023 | 11:43 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Piper Sandler raised the price target for Chegg, Inc. from $11 to $13. Chegg shares rose 19.9% to $12.03 in pre-market trading.
The raised price target by Piper Sandler indicates a positive outlook for Chegg, Inc., which is reflected in the pre-market trading rise of 19.9%.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
Goldman Sachs boosted the price target for Paymentus Holdings, Inc. from $9 to $12. Paymentus shares rose 13.5% to $12.14 in pre-market trading.
The boosted price target by Goldman Sachs indicates a positive outlook for Paymentus Holdings, Inc., which is reflected in the pre-market trading rise of 13.5%.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
JP Morgan increased the price target for Sovos Brands, Inc. from $21 to $23. Sovos Brands shares gained 25.2% to close at $22.56 on Monday.
The increased price target by JP Morgan indicates a positive outlook for Sovos Brands, Inc., which is reflected in the share gain of 25.2% on Monday.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
Atlantic Equities cut Biogen Inc.'s price target from $282 to $275. Biogen shares rose 0.8% to $273.49 in pre-market trading.
The cut in price target by Atlantic Equities indicates a slightly negative outlook for Biogen Inc., despite a small rise in pre-market trading.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100